Strategic partnerships Konovo has a history of consolidating capabilities from multiple firms and is expanding through strategic alliances, such as the recent partnership with Litmys and collaboration with Metaforms. Target opportunities: cross-sell data and audience solutions via partners, co-developed research panels, and integrated AI-enabled survey tools to accelerate client decision timelines.

_expansion_ leadership Significant executive hires in 2025-2026, including Chief Commercial Officer and MD for India, plus a Chief Compliance and Privacy Officer. This signals aggressive geographic and regulatory expansion. Sales teams should pursue global healthcare brands and emerging markets in India by offering localized access, governance-compliant data, and scalable audience solutions.

Regulatory & privacy focus Appointment of a chief compliance and privacy officer and ongoing data partnerships indicate a strong emphasis on governance, security, and consent. Propose premium, privacy-forward data solutions, SOC 2/ISO-aligned processes, and transparent data provenance to win risk-conscious pharmaceutical and device clients.

Comprehensive audiences Konovo boasts the broadest reach of physicians, KOLs, patients, caregivers, and allied professionals across Americas, Europe, and Asia. Gap-to-fill opportunities exist in multinational trials, post-market surveillance, and patient-centric outcomes research requiring diverse panels and rapid recruitment.

Financial scale & credibility Revenue is estimated between $50M and $100M with a mid-market footprint and a global client base. Leverage their scale to offer enterprise-grade research programs, bundled services, and bundled technology across insights, recruitment, and data management to target mid-to-large pharma and CROs seeking efficiency gains.